| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
24,536 | 11,536 | |||||
General and administrative | ||||||
20,869 | 2,974 | |||||
Total operating expenses | ||||||
45,405 | 14,510 | |||||
Loss from operations | ||||||
-45,405 | -14,510 | |||||
Other income (expense): | ||||||
Interest income | ||||||
2,517 | 25 | |||||
Interest income, net (Note 4) | ||||||
11 | -407 | |||||
Accretion of debt discount (Note 4) | ||||||
945 | 2,176 | |||||
Change in fair value of derivative (Note 4) | ||||||
-135 | -444 | |||||
Total other income (expense), net | ||||||
1,448 | -3,002 | |||||
Net loss before income taxes | ||||||
-43,957 | -17,512 | |||||
Income tax provision | ||||||
0 | 0 | |||||
Net loss attributable to common stockholders | ||||||
-43,957 | -17,512 | |||||
Net loss per share, basic and diluted (Note 7) | ||||||
-3.68 | -4,378,000.00 | |||||
Weighted average common shares outstanding used in computing net loss per share, basic and diluted | ||||||
11,958 | 0 | |||||